This whitepaper examines how pharmaceutical and MedTech organizations can modernize supply chains strained by legacy systems, siloed operations, compliance complexity, and volatile demand. It outlines how AI-driven planning, real-time visibility, and integrated execution improve forecasting accuracy, inventory management, traceability, and resilience across the life sciences ecosystem. The report highlights growing regulatory pressures such as DSCSA and UDI requirements, while emphasizing the need for connected supply chain networks capable of adapting to disruptions without compromising patient outcomes or compliance. Blue Yonder positions intelligent orchestration and unified data visibility as critical enablers for scalable, compliant, and agile life sciences supply chains.

Join for free to read